The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients with Biochemical Failure Status Post Salvage or Radical Radiation Therapy

NCT02573636 · clinicaltrials.gov ↗
RECRUITING
Status
208
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Sir Mortimer B. Davis - Jewish General Hospital